GGrantIndex
← Search

S4 TO 108 NCATS GENE THERAPY VECTOR

$3,795,000N02FY2021ODNIH

Medical Science & Computing, Llc, Rockville MD

Investigators

Abstract

Produce and deliver a research grade gene therapy vector for a potential lead candidate for hereditary methylmalonic acidemias using AAV9 platform-based gene therapy vector platform.

View original record on NIH RePORTER →